Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 1
1978 1
1979 1
1980 3
1981 3
1982 2
1983 3
1984 4
1985 3
1986 5
1987 2
1988 3
1989 1
1990 2
1991 3
1992 4
1993 4
1994 6
1995 4
1996 6
1997 6
1998 6
1999 5
2000 7
2001 3
2002 6
2003 8
2004 5
2005 6
2006 6
2007 3
2008 12
2009 3
2010 6
2011 5
2012 5
2013 9
2014 4
2015 3
2016 5
2017 2
2018 3
2019 7
2020 4
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

190 results
Results by year
Filters applied: . Clear all
Page 1
Exploiting poly(I:C) to induce cancer cell apoptosis.
Bianchi F, Pretto S, Tagliabue E, Balsari A, Sfondrini L. Bianchi F, et al. Among authors: balsari a. Cancer Biol Ther. 2017 Oct 3;18(10):747-756. doi: 10.1080/15384047.2017.1373220. Epub 2017 Sep 7. Cancer Biol Ther. 2017. PMID: 28881163 Free PMC article. Review.
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer.
Di Modica M, Gargari G, Regondi V, Bonizzi A, Arioli S, Belmonte B, De Cecco L, Fasano E, Bianchi F, Bertolotti A, Tripodo C, Villani L, Corsi F, Guglielmetti S, Balsari A, Triulzi T, Tagliabue E. Di Modica M, et al. Among authors: balsari a. Cancer Res. 2021 Apr 15;81(8):2195-2206. doi: 10.1158/0008-5472.CAN-20-1659. Epub 2021 Jan 22. Cancer Res. 2021. PMID: 33483370 Free article.
Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade.
Lo Russo G, Moro M, Sommariva M, Cancila V, Boeri M, Centonze G, Ferro S, Ganzinelli M, Gasparini P, Huber V, Milione M, Porcu L, Proto C, Pruneri G, Signorelli D, Sangaletti S, Sfondrini L, Storti C, Tassi E, Bardelli A, Marsoni S, Torri V, Tripodo C, Colombo MP, Anichini A, Rivoltini L, Balsari A, Sozzi G, Garassino MC. Lo Russo G, et al. Among authors: balsari a. Clin Cancer Res. 2019 Feb 1;25(3):989-999. doi: 10.1158/1078-0432.CCR-18-1390. Epub 2018 Sep 11. Clin Cancer Res. 2019. PMID: 30206165 Free article.
HER2 as a prognostic factor in breast cancer.
Ménard S, Fortis S, Castiglioni F, Agresti R, Balsari A. Ménard S, et al. Among authors: balsari a. Oncology. 2001;61 Suppl 2:67-72. doi: 10.1159/000055404. Oncology. 2001. PMID: 11694790 Review.
Natural antibodies to IL-2.
Balsari A, Caruso A. Balsari A, et al. Biotherapy. 1997;10(1):25-8. doi: 10.1007/BF02678214. Biotherapy. 1997. PMID: 9261547 Review.
HER2 as a target for breast cancer therapy.
Tagliabue E, Balsari A, Campiglio M, Pupa SM. Tagliabue E, et al. Among authors: balsari a. Expert Opin Biol Ther. 2010 May;10(5):711-24. doi: 10.1517/14712591003689972. Expert Opin Biol Ther. 2010. PMID: 20214497 Review.
190 results